1. Frei M., Kuster L., Gardosch von Krosigk P-P. et al. Moxonidine and hydrochlorothiazide in combination: a synergistic antihypertensive effect// J. Cardiovasc. Pharmacol. - 1994; 24:S25-S28.
2. Fiorentini C., Guillet C., Guazzi M. Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients// Arch Mal Coeur Vaiss. 1989 Dec;82 Spec No 5:39-46;
3. Lotti G., Gianrossi R. Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance// Fortscher Med. 1993; 111:429-432;
4. Scemama M., Fevrier B., Beucler I., Dairou F. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril// J. Cardiovasc Pharmacol. 1995; 26 (Suppl. 2): S34-S39;
5. Fillastre JP
6. Letac B
7. Galinier F
8. Le Bihan G
9. Schwartz J .
10. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients// Am J Cardiol. 1988 Feb 24;61(7):81D-85D;
11. Kuppers H.E., Jager B., Heghes P.R. et al. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension// J. Hypertension 1997; 15: 93-97;
12. Panfilov V, Morris AD, Donnelly R, Scemama M, Reid JL. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension// Br J Clin Pharmacol. 1995 Dec;40(6):563-9;
13. Dallocchio M., Gosse P., Fillastre J.P. et al. Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol// Presse Med. 1991 Aug 31-Sep 7;20(27):1265-71. French;
14. Mall G
15. Greber D
16. Gharenhbaghi H
17. Wiest G
18. Amann K
19. Mattfeldt T .
20. Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats (SHR)--stereological studies on myocytes, capillaries, arteries, and cardiac interstitium// Basic Res Cardiol. 1991;86 Suppl 3:33-44
21. Sadowski Z., Szwed H., Kuch-Wocial A. et al. Regression of left ventricular hypertrophy in hypertensive patients after one year treatment with rilmenidine: double-blind, randomised, controlled study versus nifedipine. Lnt Symp 69th Annual Scientific Session of the AHA New Orleans; 1996. Abstract;
22. Van den Buuse M . Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and alpha-methyldopa in conscious rats// Eur J Pharmacol. 1997 Mar 19;322(2-3):191-9;
23. Шляхто Е.В., Конради А.О., Свиряев Ю.В. Основные результаты исследования АЛЬТАИР// Кардиоваскулярная терапия и профилактика. - 2006, №1. - С. 21-30. Шляхто Е.В., Конради А.О. Переносимость терапии рилменидином и его сочетания с амлодипином у больных гипертонической болезнью. (По данным исследования АЛЬТАИР)// Артериальная гипертензия. - 2006, Т.12;
24. Конради А.О., Свиряев Ю.В. Динамика массы тела, уровней глюкозы и липидов плазмы на фоне приема рилменидина в монотерапии и в комбинации с амлодипином (по результатам исследования АЛЬТАИР)// Артериальная гипертензия. - 2006. - Т. 12, №2. - С. 141-144;
25. Kamisaki Y., Ishikawa T., TakaoY. et al. Binding ofp-aminoclonidine to two sites, alpha 2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain// Brain Res. 1990; 514 (1):15-21;
26. Stroes JW, Putters J, van Rijn HJ. An improved spectrophotometric procedure for the determination of urinary metanephrines// J Clin Chem Clin Biochem. 1987 Aug;25(8):483-6;
27. Kaan E.C., Bricker R., Frohly P. et al. Effects of agmatine and moxonidine on glucose metabolism: and integrated approach towards pathophysiological mechanisms in cardiovascular metabolic disorders// J. Cardiac. Risk Factors. - 1995, Vol.5. - P. 10-27;
28. Rosen P., Ohly P., Gleichmann H. Experimental benefit of moxonidine on glucose metabolism// J. Hypertens. - 1997, Vol. 15. - S31-38;
29. Head G.A., Burke S.L. Comparison of renal sympathetic baroreflex effects of rilmenedine and alfa-methylnoradrenaline ventrolateral medulla of the rabbit// J. Hypertens. - 2000, Vol.18. - P.1263-76;
30. Многотомное руководство по неврологии, под ред. Н. И. Гращенкова, т. 1, кн. 1, М., 1959; Clara М., Das Nervensystem des Menschen, 2 Aufl., Lpz., 1953;
31. Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C, Quyyumi AA, Brunner HG, Lenders JW. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism?// Clin Sci (Lond). 1995 May;88(5):533-42;
32. Ratge D
33. Gehrke A
34. Melzner I
35. Wisser H .
36. Free and conjugated catecholamines in human plasma during physical exercise// Clin Exp Pharmacol Physiol. 1986 Jul;13(7):543-53.
